New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 6, 2014
08:37 EDTINCYIncyte price target raised to $65 from $55 at Canaccord
Canaccord raised its price target on Incyte citing its product pipeline outlook which includes three upcoming positive data catalysts in the first half of 2014. Shares are Buy rated.
News For INCY From The Last 14 Days
Check below for free stories on INCY the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 31, 2014
13:39 EDTINCYIncyte reported strong Q2 results, says Leerink
Subscribe for More Information
13:18 EDTINCYIncyte shares defended at UBS
Subscribe for More Information
12:52 EDTINCYIncyte weakness a buying opportunity, says Brean Capital
Subscribe for More Information
07:22 EDTINCYIncyte raises FY14 Jakafi net product revenue view to $330M-$340M
Subscribe for More Information
07:15 EDTINCYIncyte reports Q2 EPS (22c), may not compare to consensus (4c)
Reports Q2 revenue $99.6M, consensus $127.19M.
July 30, 2014
08:32 EDTINCYIncyte announces clinical trial agreement with Genentech
Subscribe for More Information
July 28, 2014
07:02 EDTINCYIncyte says FDA approves supplemental labeling for Jakafi
Subscribe for More Information
July 24, 2014
06:57 EDTINCYIncyte trial miss does not impact Jakafi assumptions, says Leerink
Subscribe for More Information
July 23, 2014
16:41 EDTINCYIncyte's Ruxolitinib shows no statistical significance in primary endpoint
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use